Professor Drew Pardoll is a recognized leader in the fields of immunotherapy andcancer immunology. He is the Director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy and Co-Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center at JohnsHopkins. Dr. Pardoll has published over 300 papers as well as over 20 book chapters on the subjects ofT cellimmunology and cancer vaccines. Dr. Pardoll has founded multiple biotech companies including theimmunotherapy-based companies Amplimmune, Inc.and Jounce Therapeutics, Inc.